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Nanosuspension can be defined as sub-micron colloidal 
system which consists of poorly water-soluble drug, 
suspended in an appropriate dispersion medium stabilized 
by surfactants. Nanosuspenisons usually consist of 
colloidal carriers like polymeric resins which are inert in 
nature. They help in enhancement of drug solubility and 
thus bioavailability. Unlike microemulsions, they are also 
popular because of their non irritant nature. Flurbiprofen 
encapsulated in eudragit RS 100® and RL 100® polymer 
resins prevents myosis, which might be induced during 
extracapsular cataract surgery. Charge on the surface of 
nanoparticles facilitates its adhesion to the cornea.  Animal 
studies have revealed that anti-inflammatory effect of 
nanosuspensions was more than microsuspensions. Similar 
studies were carried out using piroxicam in eudragit RS 
100. In vivo studies in rabbits have shown significant anti-
inflammatory effects compared to microsuspensions. In 
another approach, three different types of glucocorticoids; 
hydrocortisone, prednisolone and dexamethasone were 
formulated as nanosuspensions. In vivo study in rabbits 
suggested that the nanosuspensions significantly enhanced 
the ocular absorption of glucocorticoids. These 
nanosuspensions also produce sustained drug release and 
were more effective over a longer duration. 
Nanosuspensions also impart stability to the drug in the 
formulation. 
Zidovudine/Azidothymidine (AZT), the first anti‐HIV 
compound approved for the clinical use is widely used for 
treatment of AIDS either alone or in combination with 
other antiviral agents and Zidovudine is water soluble and 
soluble at all pH ranges and absorbs throughout the 
gastrointestinal tract Zidovudine acts as a metabolic 
antagonist of thymidine and its antiviral effect is time 
dependant so a sustained release delivery of AZT is 
desired to maintain anti‐AIDS effect and avoiding severe 
side effects. By considering above facts, the present study 
was aim to 
formulate and evaluate the sustained release matrix tablets 
of Zidovudine to prolong the release of drug for extended 
period of time in order to; Improve patient compliance, 
Reduce dosing frequency, Reduce side effects, Minimum 
plasma fluctuation, Increase bioavailability of the drug. 
MATERIALS  
The model drug zidovudine was obtained from  macloids 
pharma pvt ltd. as a gift sample. All the reagents were of 
analytical grade. Double distilled water was used 
throughout the study. 
ISOLATION OF BIO POLYMER FROM 
BUCHANAIA LANZAN 
Seeds of Buchanania Lanzan were soaked in water for 2-3 
hrs and the outer cover was removed. The seeds were 
grounded into a paste and then distilled water was added 
and filtered through muslin cloth. The milk was 
centrifuged and the supernatant liquid was separated and 
acetone was added in equal quantity and kept for 24 hrs. 
The settled biomaterial was separated by centrifugation for 
5 -10 min and the isolated biomaterial was naturally dried 
and sieved through mesh size 120. The polymer obtained 
yields about 500 mg. 
FORMULATION OF ZIDOVUDINE NANO-
SUSPENSION USING THE BIO POLYMER 
Four formulations were prepared by solvent evaporation 
method. The drug was added to methylene chloride and 
polymer in distilled water separately in magnetic stirrer. 
Then an aquous solution of polymer added in drug solution 
until methylene chloride evaporates. Then subjected to 
micro centrifugation and dried the nanoparticles. 
ABSTRACT:  
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Nanoparticles were suspended in 0.9% isotonic solution to prepare nano-suspension. 
 
Table 1: Formulation Prepared 
Formulation FNS1 FNS2 FNS3 FNS4 FNS5 
Zidovudine (mg) 50 50 50 50 50 
Bio polymer (mg) 50 70 90 150 180 
Methylene chloride (ml) 15 15 15 15 15 
Distilled water q.s q.s q.s q.s q.s 
 
Evaluation parameters: 
The nano suspension was evaluated for various 
parameters:- 
1. Content uniformity  
2. Entrapment efficiency 
3. % transmittance 
4. pH 
5. Particles size and shape 
6. In-vitro drug release studies. 
Drug content uniformity 
10ml of each formulation was taken and dissolved in 10ml 
isotonic solution and kept overnight. 10 mg (similar as in 
formulation) of drug was taken and dilution was made to 
10µg/ml. The dilutions were filtered and analyzed using 
UV for their content uniformity. The absorbance of the 
formulations were read using one cm cell in a UV-Vis 
spectrophotometer. The instrument was set at 252 nm. The 
drug content in each formulation was calculated based on 
the absorbance values of known standard solutions. 
Entrapment efficacy: 
 Entrapment efficacy was calculated by following formula: 
%Entrapment efficiency= Drug content *100/Drug 
added in each formulation 
%Transmittance 
% Transmittance was measured by U.V spectroscopy at 
wavelength of 400 to 500nm. A graph for %particle range 
vs. formulations was plotted. 
pH 
The pH values were measured at 25 ◦C using a pH digital 
meter at 20 ± 1 ◦C. The formulation was brought in contact 
with the electrode of pH meter and equilibrated for 1 min. 
This method was done in triplicate and mean was 
calculated along with standard deviation. 
Particle size and shape 
Particle size and shape of the formulated microcapsules 
was determined by using Optical Microscope. 
In vitro drug release 
In vitro drug release studies were performed in a 
dissolution apparatus  using paddle method at rotation 
speed of 50 rpm. Dissolution was carried out both in acid 
media and neutral media using an equivalent of 10 mg of 
zidovudine. The volume and temperature of the dissolution 
medium were 900 ml and 37.0±0.2 °C, respectively. 
Samples were withdrawn at fixed times and were filtered 
and assayed through ultraviolet absorbance determination 
at 252 nm using a Shimadzu UV-Visible 
spectrophotometer. 
RESULTS AND DISCUSSIONS:- 
A novel bio polymer from Buchanania Lanzan was 
isolated by simplified economical process the yield was 
500 mg . The bio polymer obtained was brownish to light 
brown color with a color changing point of 190-210 
0
C. 
The bio polymer showed positive tests for the 
carbohydrates and proteins. 
 
Table 2: Physical properties of the bio material: 
S.No.  Parameters  Observations  
1 Color  light brown 
2 Odor  Characteristic  
3 Taste  Tasteless  
4 Solubility  Water  




Chemical properties of the bio material: 
S.No. Chemical constituents Observations 
1. Carbohydrate Present  
2. Protein  Present  
 
EVALAUTION PARAMETERS:- 
 pH Measurement The pH of the Nanosuspension was 
obtained in the range of 7.2 to 7.4  for all the 
formulations.Thus, the polymer is suitable for 
nanosuspension formulation. 
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 Drug content:- The drug content of the formulated 
nano suspension was found in the range of 1.96-4.59 
respectively. 
 Entrapment efficacy:- The entrapment efficacy of 
the formulated nano suspension was found to be in the 
range of 55.2%-96.6% respectively. 
 %Transmittance measurement 
 UV-Visible spectrum of pure Nanosuspension was 








Figure 2: Invitro release study of the nano suspension of zidovudine. 
DISCUSSIONS 
A novel bio polymer from Buchanania Lanzan was 
isolated by simplified economical process the yield was 
500 mg. the bio polymer obtained was of brownish to light 
brown colour with a color changing point of 190-210 
0
C. 
The bio polymer showed positive tests for the presence of 
proteins and carbohydrates. Four different formulations 
were formulated using different ratios of bio material for 
the preparation of ophthalmic films of tobramycin. The 
invitro release data in all the formulations was performed 
in zero order, first order, higuchi equation in order to 
evaluate its release mechanism.  
CONCLUSION 
Finally the experimental results had shown promising 
observations in terms of  pH, drug content, entrapment 
efficacy and % transmittance. Here the conclusion was 
drawn that the isolated bio polymer has shown its 
potentiality for formulating nano suspension. The polymer 
can serve as potential polymer for formulating various 
drug loaded nano suspensions. 
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